Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
adnectin
Description:
An engineered protein binding scaffold derived from fibronectin domains and developed for selective molecular targeting.
Primary topic:
Monoclonal and Polyclonal Antibodies Research (21%)
Related topics:
Monoclonal and Polyclonal Antibodies Research (21%),
Lipoproteins and Cardiovascular Health (17%),
Angiogenesis and VEGF in Cancer (10%),
Radiopharmaceutical Chemistry and Applications (9%)
OpenAlex ID:
keywords/adnectin
Engineered protein scaffolds as next-generation antibody therapeutics
2009
·
Michaela Gebauer
, Arne Skerra
·
Current Opinion in Chemical Biology
·
353
Adnectins: engineered target-binding protein therapeutics
2010
·
D. Lipovsek
·
Protein Engineering Design and Selection
·
250
PDF
Synthesis and Biologic Evaluation of a Novel 18 F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression
2017
·
David J. Donnelly
, R. Adam Smith
, et al.
·
Journal of Nuclear Medicine
·
197
PDF
In vitro-engineered non-antibody protein therapeutics
2017
·
Rudo Simeon
, Zhilei Chen
·
Protein & Cell
·
188
PDF
Engineered Protein Scaffolds as Next-Generation Therapeutics
2020
·
Michaela Gebauer
, Arne Skerra
·
The Annual Review of Pharmacology and Toxicology
·
173
Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering
2014
·
Tracy Mitchell
, Ginger Chao
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
142
Fast Photochemical Oxidation of Proteins (FPOP) Maps the Epitope of EGFR Binding to Adnectin
2014
·
Yuetian Yan
, Guodong Chen
, et al.
·
Journal of the American Society for Mass Spectrometry
·
92
Structures of Adnectin/Protein Complexes Reveal an Expanded Binding Footprint
2012
·
Vidhyashankar Ramamurthy
, Stanley R. Krystek
, et al.
·
Structure
·
90
PDF
Phase I and Pharmacokinetic Study of CT-322 (BMS-844203), a Targeted Adnectin Inhibitor of VEGFR-2 Based on a Domain of Human Fibronectin
2011
·
Anthony W. Tolcher
, Christopher J. Sweeney
, et al.
·
Clinical Cancer Research
·
88
Familial Hypercholesterolemia
2021
·
Julia Brandts
, Kausik K. Ray
·
Journal of the American College of Cardiology
·
86
Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trial
2023
·
Frederick Raal
, Nyda Fourie
, et al.
·
European Heart Journal
·
82
PDF
Anti-tumor effect of CT-322 as an Adnectin inhibitor of vascular endothelial growth factor receptor-2
2010
·
Roni Mamluk
, Irvith M. Carvajal
, et al.
·
mAbs
·
80
PDF
Protein scaffolds: antibody alternatives for cancer diagnosis and therapy
2022
·
Renli Luo
, Hongguang Liu
, et al.
·
RSC Chemical Biology
·
78
PDF
A Descriptor Set for Quantitative Structure‐property Relationship Prediction in Biologics
2022
·
Kannan Sankar
, Kyle Trainor
, et al.
·
Molecular Informatics
·
77
PDF
The emerging role of new protein scaffold-based agents for treatment of cancer.
2013
·
Ulrich H Weidle
, Johannes Auer
, et al.
·
PubMed
·
74
A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor
2011
·
Stuart L. Emanuel
, Linda J. Engle
, et al.
·
mAbs
·
74
PDF
The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer
2008
·
Sean P Dineen
, Laura A Sullivan
, et al.
·
BMC Cancer
·
71
PDF
Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering
2017
·
Xiaolu Han
, Gunce E. Cinay
, et al.
·
Molecular Therapy
·
67
PDF
Biopharmaceutical drug discovery using novel protein scaffolds
2006
·
Davinder S Gill
, Nitin K Damle
·
Current Opinion in Biotechnology
·
67
Non-antibody Approaches to Proprotein Convertase Subtilisin Kexin 9 Inhibition: siRNA, Antisense Oligonucleotides, Adnectins, Vaccination, and New Attempts at Small-Molecule Inhibitors Based on New Discoveries
2019
·
Toshiyuki Nishikido
, Kausik K. Ray
·
Frontiers in Cardiovascular Medicine
·
65
PDF
Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer 18F-BMS-986192
2020
·
Thijs S. Stutvoet
, Elly L. van der Veen
, et al.
·
Journal of Nuclear Medicine
·
61
PDF
Myostatin inhibitors as pharmacological treatment for muscle wasting and muscular dystrophy
2017
·
Masakazu Saitoh
, Junichi Ishida
, et al.
·
JCSM Clinical Reports
·
61
PDF
Orthogonal Mass Spectrometry-Based Footprinting for Epitope Mapping and Structural Characterization: The IL-6 Receptor upon Binding of Protein Therapeutics
2017
·
Ke Sherry Li
, Guodong Chen
, et al.
·
Analytical Chemistry
·
56
Anti-VEGFR2 and anti-IGF-1R-Adnectins inhibit Ewing’s sarcoma A673-xenograft growth and normalize tumor vascular architecture
2012
·
Maximilian Ackermann
, Brent A. Morse
, et al.
·
Angiogenesis
·
56
Ldl Cholesterol Reduction With Bms-962476, an Adnectin Inhibitor of Pcsk9: Results of a Single Ascending Dose Study
2014
·
Evan A. Stein
, Sreeneeranj Kasichayanula
, et al.
·
Journal of the American College of Cardiology
·
55
PDF
Show more works
View as search
Works count:
107
Citation count:
3,356
Year
Topic
Type